Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy

Immune checkpoint blockade (ICB) has revolutionized cancer treatment, providing remarkable clinical responses in some patients. However, the majority of patients do not respond. It is therefore crucial both to identify predictive biomarkers of response and to increase the response rates to immune ch...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Zemek, Rachael M., Chin, Wee Loong, Nowak, Anna K., Millward, Michael J., Lake, Richard A., Lesterhuis, W. Joost
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7040078/
https://ncbi.nlm.nih.gov/pubmed/32133005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00223
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items